跳至主要内容
临床试验/CTRI/2023/06/053643
CTRI/2023/06/053643尚未招募4 期

"A Comparative study of intubating conditions and haemodynamic parameters during general anaesthesia using Rocuronium and Vecuronium in patients undergoing laparoscopic surgeries.†A prospective randomized double blinded study

SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年9月6日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
100
试验地点
1
主要终点
inj. Rocuronium 0.6mg/kg provides better intubating conditions and maintains stable hemodynamic parameters during general anesthesia.

研究概览

简要总结

THIS IS A RANDOMISED DOUBLE BLINDED STUDY WHERE WE ARE COMPARING THE HEMODYNAMIC PARAMETERS AND INTUBATING CONDITIONS USING ROCURONIUM AND VECURONIUM DURING GENERAL ANAESTHESIA IN PATIENTS UNDERGOING LAPAROSCOPIC SURGERIES.

HERE WE WILL BE USING EQUIPOTENT DOSES OF BOTH THE MUSCLE RELAXANT, THAT IS THE 2 TIMES ED 95 OF BOTH THE DRUGS.

AS PER THE EXPECTED OUTCOME ROCURONIUM WILL PROVIDE MORE STABLE HEMODYNAMIC CONDITIONS AND BETTER INTUBATING CONDITIONS WHEN COMPARED TO VECURONIUM.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 未提供

排除标准

  • •ANTICIPATED DIFFICULT AIRWAY.
  • •ASA 3 AND ABOVE.
  • •ANTICIPATED MAJOR BLOOD LOSS.
  • •MAJOR SYSTEMIC DISEASES.

结局指标

主要结局

inj. Rocuronium 0.6mg/kg provides better intubating conditions and maintains stable hemodynamic parameters during general anesthesia.

时间窗: baseline

次要结局

  • To assess the adverse drug reaction caused by either of the the muscle relaxant used and also the time interval required between the intubating dose and 1st top up.(baseline)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验